Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

First Murder By Propofol Reported By Leading Anesthesia Journal
Recent questions about the death of Michael Jackson have focused media attention on the commonly used intravenous anesthetic propofol. In the April 2009 issue of Anesthesia & Analgesia, the leading clinical journal for anesthesiologists, Robert R. Kirby, James M. Colaw and Michael M. Douglas reported on a 24-year-old woman whose 2005 death was attributed to propofol toxicity.

Survivors Of Childhood Central Nervous System Cancer Face Persistent Risks As Adults
Long-term survivors of childhood central nervous system (CNS) malignancies remain at risk for death and are at increasing risk for developing subsequent cancers and chronic medical conditions over time, according to a new study published online June 17 in the JNCI.
News of the day
Medical Expulsive Therapy As An Adjunct To Improve Shockwave Lithotripsy Outcomes: A Systematic Review And Meta-Analysis
UroToday.com - Over the past decade, the most significant advance, in my mind, with regard to the treatment of the distal ureteral stone, has been the advent of medical expulsive therapy as described by Porpiglia and colleagues in 2000, and corroborated by many subsequent studies. Savings with this approach, according to work by Lotan and colleagues, is around $1100/patient in addition to the benefits of decreased renal colic. Stone passage rates increase anywhere from 40-100% of controls within 10 days of starting medical expulsive therapy. While a variety of medications have been used (e.g. alpha blockers, steroids, calcium channel blockers), the alpha blockers (i.e. tamsulosin and alfuzosin) appear to be effective and well tolerated.
Health Insurance

The HUGO Journal Joins Springer's Biomedical Sciences Portfolio

Starting in October 2009, Springer will publish The HUGO Journal in cooperation with the Human Genome Organisation (HUGO). Formerly published at Springer as Genomic Medicine, The HUGO Journal has a new design, new features and a new editorial team. Members of HUGO will receive free access to the journal online and be able to purchase print subscriptions at discounted rates. The HUGO Journalwill focus on discoveries arising from the basic, clinical and population explorations of the human genome and genomes of organisms relevant to human health. The journal will publish primary research papers of the highest quality as well as in-depth review articles on important topics pertaining to genomic medicine, human genetics, computational genomics and genomic technologies. The HUGO Journal will also publish key consensus reports and policy guidelines from the HUGO Council and its subcommittees. Several new sections featuring the description and utility of genomic databases as well as special reports on innovation and technology advances will be offered to foster the exchange of information relevant to genomic scientists. "We are delighted to work with Springer to publish The HUGO Journal. In line with our new direction to focus on enhancing genomic capabilities, The HUGO Journal will definitely be an important instrument to promote knowledge, excitement and networking," said Professor Edison Liu, President of HUGO and Executive Director of the Genome Institute of Singapore. Peter Butler, Editorial Director, Biomedical Unit at Springer, said, "We are very pleased to be partnering with such a prestigious society. Working together with the Human Genome Organisation, we look forward to supporting the advance of genomics research. The Human Genome Organisation, an international organisation established in 1988, encourages collaboration among genome scientists around the world. Now that the human genome has been sequenced, the organisation is seeking the biological meaning of its information content and to this end, is focusing on the medical implications of genomic knowledge. HUGO also works to improve the genomic capabilities in the emerging countries of the world. Springer is a leading global scientific publisher of books and journals, delivering quality content through innovative information products and services. It publishes close to 500 academic and professional society journals. Springer is part of the publishing group Springer Science+Business Media. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 6,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,000 employees. The HUGO Journal ISSN: 1877-6558 (print version), ISSN: 1877-6566 (electronic version) Joan Robinson Springer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009